Near Infrared Imaging

Name

Near Infrared Imaging

Legal name

Near Infrared Imaging, Inc.

Website

https://nearinfraredimaging.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Imaging Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)

akta.pro secondary industries

Medical Imaging AI (HDAAAEAH), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

• Near-infrared imaging
• Vein visualization devices
• Medical imaging hardware
• Vein finder technology
• NIR diagnostic imaging

Headquarters

HQ city

Wrentham

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Marketing or Sales, Personnel

Revenue model

1. Vein-Eye Carry Device Sales: Sale of the Vein-Eye Carry hardware device (3rd generation) to medical facilities through distributor network. Single one-time hardware purchase. MSRP $2,799 USD.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Near Infrared Imaging invents, designs, and distributes near-infrared vein visualization medical devices. The flagship product is the Vein-Eye Carry, a third-generation 5-pound portable NIR imaging device that produces real-time FHD video of subcutaneous veins — showing depth, size, and direction in all patients including difficult cases — and detects infiltration and extravasation of medicine into surrounding tissue (MSRP $2,799 USD). The company is layering AI algorithms over the NIR platform to add automated hemorrhage detection, predictive risk mapping for cosmetic surgery, and enhanced non-contact biometrics via the AI Buddy Medical Diagnostic Suite.

Product overview

Near Infrared Imaging offers a focused portfolio centered on the Vein-Eye Carry, a third-generation near-infrared (NIR) vein imaging device providing FHD visualization of veins for medical professionals. The company is expanding this core product with AI capabilities through strategic partnerships, including the AI Buddy medical diagnostic suite developed with Remergify and Farrington Capital Group, which integrates NIR imaging with AI software for enhanced diagnostics and post-surgical monitoring.

Differentiator

Problem solved

Functional benefit

Brands

• Vein-Eye Carry: 3rd generation near-infrared vein visualization device weighing 5 lbs, designed for use in various medical settings including home infusion therapy, ambulances, medical evacuation vehicles, and blood testing laboratories. MSRP: $2,799 USD.

Products and services

• Vein-Eye Carry A 5-pound portable third-generation near-infrared vein imaging device providing real-time full high definition (FHD) video of subcutaneous veins — clearly showing depth, exact size, and direction of veins in all patients including difficult cases. Detects infiltration and extravasation of medicine into surrounding tissue. Designed for use anywhere a vein must be punctured, including home infusion therapy, ambulances, medical evacuation vehicles, and blood testing laboratories. Sold exclusively through medical equipment distributors at MSRP $2,799 USD.
• AI Buddy Medical Diagnostic Suite A partnership-developed medical diagnostic suite that combines Near Infrared Imaging's NIR vein imaging hardware with AI software to enable ophthalmic diagnostics, post-surgical monitoring, and biometric medical record access. Targets FDA 510(k) clearance and CE Marking with HIPAA and GDPR compliance, and is intended for deployment across advanced surgical facilities and mobile medical units serving underserved populations globally.

Quantifiable outcome

• 25% first-attempt failure rate in vein punctures addressed by Vein-Eye Carry's real-time NIR visualization
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• RemergifycoreStrategic or Co-development Partner · 7 April 2026Strategic worldwide partnership with Remergify and Farrington Capital Group to launch the 'AI Buddy' medical diagnostic suite. Integrates near-infrared imaging hardware with AI software for ophthalmic diagnostics, post-surgical monitoring, and biometric medical record access. Targets FDA 510(k) clearance and CE Marking, with HIPAA and GDPR compliance. Deployment planned across advanced surgical facilities and mobile medical units serving underserved populations globally.
• Farrington Capital GroupcoreStrategic or Co-development Partner · 7 April 2026Partnership with Farrington Capital Group to launch the 'AI Buddy' medical diagnostic suite combining NIR imaging hardware with AI software. Farrington Capital Group separately announced integration of Raspberry Pi Compute Modules to power the 'AI Health Buddy' for NIR medical technology. Pursuing FDA 510(k) clearance and CE Marking with HIPAA and GDPR compliance.
• RemergifycoreStrategic or Co-development Partner · 19 March 2026Strategic partnership with Remergify to integrate artificial intelligence into near-infrared medical technology. Goal to commercialize the Vein-Eye Platform for deployment across global medical markets, with initial focus on surgical and biometric applications.
• Farrington Capital GroupcoreStrategic or Co-development Partner · 19 March 2026Strategic partnership with Farrington Capital Group to integrate AI into near-infrared medical technology, commercializing the Vein-Eye Platform for global medical markets with focus on surgical and biometric applications. Farrington Capital Group is also integrating Raspberry Pi Compute Modules to develop the 'AI Health Buddy' for NIR medical technology.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• AccuVein: AccuVein is the market-leading vein visualization company, selling NIR-based vein illumination devices (AV500, AV400) to hospitals, blood draw labs, and aesthetics clinics worldwide. It is the closest direct competitor to the Vein-Eye Carry in portable NIR vein finder hardware, distribution model, and clinical use cases (IV access, blood draws).
• Christie Medical Holdings (VeinViewer): Christie's VeinViewer line uses NIR technology to project real-time vein maps onto the patient's skin and is widely deployed in U.S. hospitals and infusion centers. Like NII, it targets IV access failure reduction and competes head-to-head with the Vein-Eye Carry for hospital and EMS contracts.
• VueTek Scientific: VueTek Scientific manufactures the Veinsite vein visualization system, a portable NIR-based device for healthcare professionals. It directly overlaps with NII's product functionality in vein illumination and shares similar hospital and clinical distribution channels.
• Evena Medical: Evena Medical produces wearable and portable vein imaging devices (e.g., Eyes-On Glasses) using NIR technology for clinicians performing IV access. It competes in the same vein visualization niche with a focus on portability and point-of-care use, directly comparable to the Vein-Eye Carry.

Broad incumbents

• BK Medical (Analogic): BK Medical, part of Analogic, is an established intraoperative and surgical ultrasound imaging company whose surgical guidance solutions overlap with NII's stated intraoperative NIR bleeding detection roadmap. It represents a broader incumbent with deeper regulatory and sales infrastructure in surgical imaging.
• GE HealthCare: GE HealthCare is a global medical imaging incumbent with broad portfolios spanning ultrasound, surgical visualization, and AI-enabled diagnostics. While not focused on portable vein finders, it competes for hospital capital budgets and AI imaging partnerships that NII's AI Buddy roadmap targets.
• Siemens Healthineers: Siemens Healthineers offers a broad suite of medical imaging, surgical guidance, and AI diagnostic tools and is a major incumbent in healthcare AI imaging. It represents the competitive ceiling NII is positioning its AI Buddy diagnostic suite against for hospital procurement.
• Philips Healthcare: Philips Healthcare provides patient monitoring, diagnostic imaging, and AI-enabled clinical solutions globally. It is a broad incumbent relevant to NII's aspirations in AI diagnostic imaging and biometric medical record workflows within hospital systems.

Emerging players

• Remergify: Remergify is an AI/medical-imaging emerging player that has signed a strategic worldwide partnership with NII to build the AI Buddy diagnostic suite. As both collaborator and adjacent AI imaging peer, it is a key ecosystem partner and partial competitor in AI-enabled vein/surgical imaging.
• Medipim (Dermatoscope / vein imaging startups): Medipim and similar emerging imaging startups are pursuing AI-augmented medical imaging for dermatology and vascular applications. They overlap with NII's AI imaging roadmap as emerging niche players that could compete for AI imaging partnerships and clinical adoption.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/430019100777754

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Near Infrared Imaging